Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
---|
11/13/2002 | EP1256625A1 Immortalized vascular adventitial cell line |
11/13/2002 | EP1255853A2 Methods of protein destabilization and uses thereof |
11/13/2002 | EP1255837A2 Il-17 like molecules and uses thereof |
11/13/2002 | EP1255824A2 Non-human transgenic animals for the study of neurodegenerative syndromes |
11/13/2002 | EP1255819A2 Human kinases |
11/13/2002 | EP1255812A1 Process for the production of non-human embryos of high-genetic value and of predetermined sex |
11/13/2002 | EP1255774A1 Transgenic animal model for obesity expressing foxc2 |
11/13/2002 | EP1255437A1 Transgenic animal expressing a multiple mutated form of presenilin 1 |
11/13/2002 | CN1379816A Human G-protein coupled receptor |
11/13/2002 | CN1379246A Reagent box for diagnosing pregnancy and method of diagnosing pregnancy using said reagent box |
11/13/2002 | CN1378778A Technique for nursing sucking piglet without sow |
11/12/2002 | US6479729 Mouse model for ocular neovascularization |
11/12/2002 | US6479292 Genetic alteration in plants using single-stranded oligodeoxynucleotide vectors |
11/12/2002 | US6479232 Human xenografts for microbicide testing and anatomical modeling |
11/07/2002 | WO2002088366A1 Von willebrand factor (vwf)-cleaving enzyme |
11/07/2002 | WO2002088351A1 Modified organs and cells for xenotransplantation |
11/07/2002 | WO2002088346A2 A system for inducible expression in eukaryotic cells |
11/07/2002 | WO2002088305A2 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression |
11/07/2002 | WO2002087321A2 Apparatus and method for mass production of insecticidal nematodes |
11/07/2002 | WO2002028897A3 Human g-protein coupled receptor and uses thereof |
11/07/2002 | WO2002024930A3 Artificial ubiquitous chromatin opening elements (ucoe) |
11/07/2002 | WO2001046406A9 New qtl's on chromosomes x, 2, 6 and 7 of pigs |
11/07/2002 | US20020166138 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor |
11/07/2002 | US20020166134 Cardiomyocytes with enhanced proliferative potenial, and methods for preparing and using same |
11/07/2002 | US20020166132 System for regulating in vivo the expression of a transgene by conditional inhibition |
11/07/2002 | US20020166130 Expression of active human factor IX in mammary tissue of transgenic animals |
11/07/2002 | US20020165383 Tenebrio antifreeze proteins |
11/07/2002 | US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor |
11/07/2002 | US20020165347 Polypeptide for use in the diagnosis, prevention and treatment of arteriosclerosis and vascular restenosis |
11/07/2002 | US20020165154 Lipoprotein-regulating medicaments |
11/07/2002 | US20020164748 Enzymatic polypeptide for use in the treatment of inflammation, autoimmune and tissue rejection disorders |
11/07/2002 | US20020164719 Targeting pharmaceutical agents to injured tissues |
11/07/2002 | US20020164715 Nucleotide seqences coding polypeptides for use in the treatment and diagnosis of cancer |
11/07/2002 | US20020164307 Replacement of damage cells |
11/07/2002 | CA2445945A1 Modified organs and cells for xenotransplantation |
11/07/2002 | CA2385187A1 Method for observing human endometrial cells in living animals |
11/06/2002 | EP1254260A1 Methods for diagnosing and treating heart disease |
11/06/2002 | EP1254238A2 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
11/06/2002 | EP1254235A2 Drug metabolizing enzymes |
11/06/2002 | EP1254210A2 Method for cloning animals with targetted genetic alterations by transfer of long-term cultured male or female somatic cell nuclei, comprising artificially-induced genetic alterations, to enucleated recipient cells |
11/06/2002 | EP1254177A1 RUMINANT MHC CLASS I-LIKE Fc RECEPTORS |
11/06/2002 | EP1253823A1 Controlling offspring's sex ratio by targeting transgenes onto the sex chromosomes |
11/06/2002 | EP0953039A4 Animal models of human prostate cancer progression |
11/05/2002 | US6476290 Transgenic tilapia comprising a humanized insulin gene |
11/05/2002 | US6475781 Trans-dominant suppressor genes for oligomeric proteins |
11/05/2002 | US6475746 Method of obtaining a composition comprising a 5-HT1D selective compound |
11/05/2002 | US6475723 Pathogenic tau mutations |
11/05/2002 | US6475718 Genetically engineered eukaryotic cell; for prevention of viral infections; viricides |
11/05/2002 | US6475485 Two novel human cathepsin proteins |
11/05/2002 | US6474259 Apparatus and method for mass production of insecticidal nematodes |
11/05/2002 | EP0792098A4 Enhancing growth and pearl production in mollusks |
10/31/2002 | WO2002086119A1 Transformed silkworm producing human collagen |
10/31/2002 | WO2002086113A2 Enzyme and snp marker for disease |
10/31/2002 | WO2002086103A1 A method of nuclear transfer |
10/31/2002 | WO2002086098A2 A lac operator-repressor system |
10/31/2002 | WO2002086064A2 Inducible expression of transfected genes |
10/31/2002 | WO2002085945A2 Vhh single heavy chain antibody and a method for its preparation in a mammal |
10/31/2002 | WO2002085944A2 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |
10/31/2002 | WO2002085943A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
10/31/2002 | WO2002085306A2 Use of follistatin to increase muscle mass |
10/31/2002 | WO2002085287A2 Minimal adenoviral vectors for immunization |
10/31/2002 | WO2002064727A3 Microinjection assembly and methods for microinjecting and reimplanting avian eggs |
10/31/2002 | WO2002042455A3 Modifier of organelle metalbolism |
10/31/2002 | WO2002034913A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
10/31/2002 | WO2002029075A3 Multiple inducible gene regulation system |
10/31/2002 | WO2002016566A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
10/31/2002 | WO2002000262A3 Modulation of chromosome function by chromatin remodeling agents |
10/31/2002 | WO2001059152A3 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
10/31/2002 | WO2001049844A9 Compositions and methods for gene silencing |
10/31/2002 | US20020162134 Primordial germ cell-based germ line production of birds |
10/31/2002 | US20020162130 Transgenic mouse expressing the human cyclooxygenase-2 gene and neuronal cell cultures derived therefrom |
10/31/2002 | US20020162129 Prevention and treatment of alzheimer's disease |
10/31/2002 | US20020162123 For therapy of tumors |
10/31/2002 | US20020161196 Trail receptors nucleic acids encoding the same and methods of use thereof |
10/31/2002 | US20020161195 Trail receptors, nucleic acids encoding the same, and methods of use thereof |
10/31/2002 | US20020160970 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
10/31/2002 | US20020160481 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
10/31/2002 | US20020160473 Far red shifted fluorescent proteins |
10/31/2002 | US20020160448 Human c-Maf compositions and methods of use thereof |
10/31/2002 | US20020160410 Amplification of nucleic acids |
10/31/2002 | DE10217066A1 Composition useful for treatment of central nervous system disorders, e.g. Alzheimer's disease comprises modulator of neuron-specific calcium sensor-1 |
10/31/2002 | CA2807478A1 Use of follistatin to increase muscle mass |
10/31/2002 | CA2483507A1 Enzyme and snp marker for disease |
10/31/2002 | CA2445255A1 Vhh single heavy chain antibody and a method for its preparation in a mammal |
10/31/2002 | CA2445011A1 Transformed silkworm producing human collagen |
10/31/2002 | CA2444621A1 A method of nuclear transfer |
10/31/2002 | CA2439693A1 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
10/30/2002 | EP1252818A1 Method of transferring mutant mitochondrial dna into genital cells |
10/30/2002 | EP1252315A2 Method for the production of a protein |
10/30/2002 | EP1252305A2 Full-length human cdnas encoding potentially secreted proteins |
10/30/2002 | EP1252300A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
10/30/2002 | EP1252188A2 G-protein coupled receptors |
10/30/2002 | CN1377424A Methods of reparing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer |
10/30/2002 | CN1377225A Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine |
10/29/2002 | US6472584 Production of membrane proteins in the milk of transgenic mammals |
10/29/2002 | US6472583 Plasmid-based mutation detection system in transgenic fish |
10/29/2002 | US6472374 Endometrial function |
10/29/2002 | US6472174 Polypeptides bind to the hek or elk receptor, the nucleic acids encoding such polypeptides; genetic engineering |
10/29/2002 | US6471990 A dialkylamide glycylspermine; dioctadecylamide glycylspermine particularly preferred to help the gene to be transported into the target cells |
10/25/2002 | EP0981604A4 Targeted gene modification by parvoviral vectors |